Embecta Corp. vs Indivior PLC
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Indivior PLC is the larger company by market value: $4.9 B against $366 M for Embecta Corp., 13 times as much (market caps of Oct 29, 2026 for Embecta Corp. and Aug 1, 2026 for Indivior PLC). Indivior PLC's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
- Indivior PLC had more revenue: $1.2 B in the year to December 2025 against $1.1 B for Embecta Corp. in the year to September 2025.
- Indivior PLC earned more: net income of $210 M against $95 M for Embecta Corp.
- Indivior PLC keeps more of each dollar of sales: a net margin of 16.9% against 8.8% for Embecta Corp.
- On price to earnings, Indivior PLC trades at 10.8× and Embecta Corp. at 4.2×: investors pay more for each dollar of Indivior PLC's profit.
- Indivior PLC's revenue grew faster in its latest fiscal year: +4.3% against -3.8% for Embecta Corp.
- On the Piotroski F-score, a nine-point test of improving finances, Embecta Corp. scores 6 and Indivior PLC 4. Their Altman Z-scores put Embecta Corp. in the distress zone and Indivior PLC in the safe zone.
Market value, the same start = 100
From Dec 2022: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Embecta Corp. EMBC · #13,895 in the world | Indivior PLC INDV · #3,650 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇬🇧 UK |
| Sector | Healthcare | Healthcare |
| Industry | — | Pharmaceutical |
| Founded | — | 1994 |
| Size | ||
| Market cap | $366 M | $4.9 B |
| Revenue | $1.1 B | $1.2 B |
| Net income | $95 M | $210 M▲ best |
| Employees | 1,850 | — |
| Valuation | ||
| P/E ratio | 4.2× | 10.8× |
| Price to sales | 0.4× | 3.5× |
| Free cash flow yield | 49.8%▲ best | -1.9% |
| Profitability | ||
| Gross margin | 62.6% | 80.2%▲ best |
| Operating margin | 22.4%▲ best | 21.1% |
| Net margin | 8.8% | 16.9%▲ best |
| Return on invested capital | 31.1% | — |
| Growth | ||
| Revenue growth | -3.8% | 4.3%▲ best |
| Revenue growth, 3 years a year | -1.5% | 11.2%▲ best |
| Earnings per share growth | 20.9% | — |
| Financial strength | ||
| Net debt to EBITDA | 4.2× | 0.3×▲ best |
| Interest cover | — | 6.9× |
| Cash | ||
| Free cash flow margin | 16.9%▲ best | -7.5% |
| Shareholder returns | ||
| Dividend yield | 9.6% | — |
| Shareholder yield | 9.6%▲ best | 0.2% |
| Strength scores | ||
| Piotroski F-score | 6 of 9▲ best | 4 of 9 |
| Altman Z-score zone | distress | safe |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Aug 2026; ratios FY2025 |
Questions and answers#
Which is bigger, Embecta Corp. or Indivior PLC?
Indivior PLC is the larger company by market value: $4.9 B against $366 M for Embecta Corp., 13 times as much (market caps of Oct 29, 2026 for Embecta Corp. and Aug 1, 2026 for Indivior PLC). Indivior PLC's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
Which makes more money, Embecta Corp. or Indivior PLC?
Indivior PLC had more revenue: $1.2 B in the year to December 2025 against $1.1 B for Embecta Corp. in the year to September 2025. Indivior PLC earned more: net income of $210 M against $95 M for Embecta Corp.
Which is more profitable, Embecta Corp. or Indivior PLC?
Indivior PLC keeps more of each dollar of sales: a net margin of 16.9% against 8.8% for Embecta Corp.
Is Embecta Corp. cheaper than Indivior PLC?
On price to earnings, Indivior PLC trades at 10.8× and Embecta Corp. at 4.2×: investors pay more for each dollar of Indivior PLC's profit. A lower multiple is not by itself a better buy: it also reflects expected growth, risk and accounting.
Which is growing faster, Embecta Corp. or Indivior PLC?
Indivior PLC's revenue grew faster in its latest fiscal year: +4.3% against -3.8% for Embecta Corp.
Which is financially stronger, Embecta Corp. or Indivior PLC?
On the Piotroski F-score, a nine-point test of improving finances, Embecta Corp. scores 6 and Indivior PLC 4. Their Altman Z-scores put Embecta Corp. in the distress zone and Indivior PLC in the safe zone.